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H19 is shown by Venkatraman et al. (2013), using maternal-allele-specific deletion of the differentially meth-
ylated region, to maintain hematopoietic stem cell repopulating ability through a miR-675-Igf1r signaling
circuit. This work establishes function in somatic stem cells for another member of a putative imprinted
gene network that may influence organismal growth.Anyone with teenagers (or anyone who
has been a teenager) is familiar with the
tug-of-war between progeny and parent
to exert control. What we forget is that
long into adulthood, our parental ge-
nomes still maintain their influence.
We are reminded of this imposition
when reading a recent paper in Nature
by Linheng Li and colleagues, who have
explored the role of the H19 locus in regu-
lation of hematopoietic stem cells (HSCs)
(Venkatraman et al., 2013). H19 is an ‘‘im-
printed’’ gene, meaning that its expres-
sion is dictated by one parent. In this
case, the father’s genome is the disci-
plinarian; expression of H19 is only
permitted from the allele originating from
the mother (Figure 1).
Li and colleagues observed that H19
is highly expressed in long-term hemato-
poietic stem cells (HSCs) and downre-
gulated (by mechanisms independent of
imprinting) in differentiated blood prog-
eny. They studied its function in HSCs by
using mice in which the locus controlling
imprinting, the differentially methylated
region (DMR), was conditionally deleted
by Mx1-Cre induction. When removed
from the maternally derived allele (from
which it is normally transcribed), H19
was no longer expressed and long-
term HSC numbers were depleted, but
knockout (KO) of the DMR from the pater-
nally derived allele (from which H19 is
normally silent) had no effect. Stem cells
from the maternal-allele KO were less
quiescent than controls and were signifi-
cantly impaired in their ability to regen-
erate the peripheral blood lineages after
bone marrow or stem cell transplantation.
The authors further showed that the KO
phenotype was due at least in part to up-
regulation of the Igf2- Igf1 receptor (Igf1r)signaling pathway. Igf2 is another im-
printed gene expressed from the same
genomic region as H19, but Igf2 expres-
sion is permitted only from the paternal
allele while the maternal allele is silent
(Figure 1). Igf2 is a ligand for the Igf1r in
the adult. Maternal-alleleH19 KO resulted
in increased Igf2 expression, increased
signaling through the Igf1r, and loss of
downstream FoxO3-mediated inhibition
of HSC cell cycle activity.
Igf1r signaling was augmented by loss
of expression of miR-675, which ema-
nates from the H19 locus and normally
targets the transcript of the Igf1r, re-
pressing its translation. Overexpression
of miR-675 resulted in more quiescent
HSCs and reduced Igf1r protein levels.
To more definitively link the maternal
H19 KO phenotype to increased Igf1r
signaling, the authors showed that
concomitant Igfr1 KO partially rescued
the H19 KO phenotype. Together, these
data establish a novel proliferation control
circuit for HSCs.
While providing new insight into regula-
tion of HSCs, this work also lends further
support for an intriguing idea that im-
printed genes, as a group, play a special
role in somatic stem cells. Previous work
by our own group showed that most
imprinted genes that are expressed in
the hematopoietic system are predomi-
nantly transcribed in HSCs relative to their
differentiated progeny (Berg et al., 2011),
whether they are paternally or maternally
authorized genes. Of ten imprinted genes
that are part of a coexpressed putative
‘‘imprinted gene network’’ (IGN) (Varrault
et al., 2006), three, including Necdin,
Cdkn1c (reviewed in Rossi et al., 2012),
and now H19 have been shown to func-
tion in HSCs.Cell Stem Cell 1Furthermore, imprinted gene expres-
sion also seems to prevail in at least
some other somatic stem cell types (but
not ESCs), because expression of some
members of the IGN is enriched in mouse
lung (Zacharek et al., 2011), neural (Ferro´n
et al., 2011), skin, and muscle (Berg et al.,
2011) stem cells and some of their human
counterparts (Berg et al., 2011).
What is special about imprinted
genes? Imprinted genes have largely
been studied in the context of embryonic
development where several have been
found to be involved in organismal size
and growth control (reviewed in Bartolo-
mei and Ferguson-Smith, 2011). Because
only one allele is expressed, they are
functionally hemizygous, so mutation
or loss of the expressed allele can
have serious consequences, such as
the developmental disability that occurs
in Angelman and Prader-Willi syndromes.
The evolutionary forces that have pre-
served this obscure and risky mechanism
of gene expression regulation continue to
be debated.
What are these genes doing in somatic
stem cells? The universality and speci-
ficity of imprinted gene expression in
somatic stem cells remains to be fully
established.
Perhaps when this group of genes is
expressed together, they somehow
confer a ‘‘license to grow.’’ A number of
imprinted genes are broadly and highly
expressed in rapidly growing postnatal
tissues (Lui et al., 2008), a state character-
ized by remarkable reparative/regenera-
tive capacity. As growth ceases with the
onset of sexual maturation (the dreaded
adolescent years), broad expression of
imprinted genes is extinguished, but their
expression continues in somatic stem3, August 1, 2013 ª2013 Elsevier Inc. 137
Figure 1. The H19/Igf2 Locus and Maintenance of HSC Quiescence
Schematic of the Igf2/H19 locus and themodel derived fromVenkatraman et al. (2013). From thematernal-
derived allele, H19 expression is permitted and Igf2 is inhibited by the differentially methylated region
(DMR). The paternal allele permits Igf2, and not H19, expression. The H19 locus also produces miR-
675, which inhibits translation of the Igf1 receptor (Igf1r) transcript. The Igf1r is the sensor for Igf2 signaling
in the adult; thus, H19 inhibits Igf2 signaling, and hence HSC proliferation, via a miR-675-Igf1r circuit.
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Previewscells, which are the few cells ‘‘licensed’’
for future growth and regeneration.
Although one allele of imprinted genes
is epigenetically repressed (and rarely
re-expressed), the expressed allele is
regulated just like other genes—respond-
ing to cell cycle status, injury, or differen-
tiation state. Identifying the mechanisms
that allow coordinate regulation of im-
printed genes in somatic stem cells may
provide important insights into stem cell
identity and regulation.
Imprinted genes encode a variety of
functional molecules including noncoding
RNAs (H19 and Gtl2), secreted growth
factors (Igf2 and Dlk1), transcription fac-
tors (Peg3 and Necdin), signaling mole-
cules (Grb10), and other cellular com-138 Cell Stem Cell 13, August 1, 2013 ª2013ponents. The coordinate regulation of
these molecules may enable stem cell
activation to be synchronized with de-
mands from their niche, much like the
parental conflict hypothesis suggests
they balance competing demands from
the paternal and maternal genomes to
establish fetal size; the H19-Igf2 balance,
which is the subject of the Li paper, is
emblematic of this parental tug-of-war.
In HSCs, H19 and Igf2 push and pull to
maintain the balance between prolifera-
tion (regeneration of the blood system)
and quiescence (maintenance of the
stem cell pool).
While much about imprinted genes
remains enigmatic, and their function in,
and association with, somatic stem cellsElsevier Inc.needs to be more fully explored, the
number of findings that associate these
genes with somatic stem cells strongly
suggests some central regulatory role.
Fully elucidating this relationship should
lend insights into both imprinting and
stem cells and how parental influences
extend well beyond the tumultuous
teenage years.REFERENCES
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